Home / Press / CMS Hasche Sigle advises capiton on acquisition of...

CMS Hasche Sigle advises capiton on acquisition of majority stake in KD Pharma Bexbach GmbH

13/05/2013

Berlin – In conjunction with the management team, capiton has acquired 85% of the shares in KD Pharma Bexbach GmbH from the Bioseutica Group, which is retaining a 15% stake. The parties have not disclosed the purchase price.

KD Pharma Bexbach GmbH is a leading manufacturer of highly-enriched Omega-3 fatty acids, used as ingredients for food supplements and increasingly for medicines. KD Pharma Bexbach GmbH's unique patented production technology enables it to manufacture particularly high concentrations of Omega-3 fatty acids at up to 99% purity.

capiton is additionally investing a significant amount in expanding the production facilities at KD Pharma Bexbach GmbH, which are currently running at full capacity, with the aim of boosting capacity several fold over the next 12 months.

A team led by Berlin-based corporate law partner Ralf Kurney advised capiton on all legal aspects of the transaction. capiton is a longstanding CMS Hasche Sigle client.

capiton is an independent owner-managed private equity firm that supports established SMEs as an equity capital provider in the context of growth finance and management buy-outs.

CMS Hasche Sigle

Ralf Kurney, Corporate/M&A, Lead Partner 
Christian Plodeck, Corporate/M&A 
Dr Igor Stenzel, Corporate/M&A 
Dr Tobias Teicke, Corporate/Compliance 
Dr Jens Moraht, Finance 
Jens Benninghofen, Finance 
Prof. Winfried Bullinger, Patent Law 
Dr Kai Hermes, Patent Law 
Jesko Nobiling, Tax 
Dr Nadja Fleischmann, Real Estate

Press Contact
presse@ms-hs.com

Press releases
Press Release capiton KD Pharma, 13/05/2013
Download
PDF 197.4 kB

Related people

Portrait ofRalf Kurney
Ralf Kurney
Partner
Berlin
Portrait ofWinfried Bullinger
Prof. Dr. Winfried Bullinger
Partner
Berlin
Portrait ofJesko Nobiling
Jesko Nobiling
Partner
Berlin
Portrait ofIgor Stenzel
Dr. Igor Stenzel
Partner
Berlin
Portrait ofJens Moraht
Dr. Jens Moraht
Partner
Berlin
Dr. Tobias Teicke
Show more Show less